Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

NHS to offer routine chickenpox vaccine for children from 2 January 2026

The chickenpox vaccine will be integrated into the standard NHS childhood immunisation programme starting from 2 January 2026. This move aims to reduce cases of the common childhood illness and prevent associated complications across the UK.

  • The chickenpox vaccine will become a routine part of the NHS childhood vaccination schedule from 2 January 2026.
  • Chickenpox, caused by the varicella-zoster virus, is highly contagious and typically causes an itchy rash, but can lead to severe complications.
  • Currently, the NHS offers the vaccine only to specific vulnerable groups; the new programme will extend eligibility to all eligible children.

The chickenpox vaccine is set to become a routine part of the National Health Service (NHS) childhood immunisation programme across the UK, with its inclusion scheduled from 2 January 2026. This significant change aims to reduce the prevalence of the highly contagious viral infection and mitigate the risk of serious complications.

Chickenpox, caused by the varicella-zoster virus, is a common childhood illness characterised by an itchy rash of small, fluid-filled blisters, often accompanied by a fever, headache, and general malaise. While typically mild in healthy children, it can lead to more serious health issues such as bacterial skin infections, pneumonia, or, in rare cases, encephalitis. For newborns, pregnant women, and individuals with weakened immune systems, chickenpox can be particularly severe, as highlighted by NHS guidelines.

Currently, the chickenpox vaccine is not offered routinely to all children through the NHS in the UK, unlike in some other countries. Instead, it is primarily available to specific at-risk groups, such as those with weakened immune systems or individuals who are in close contact with someone who is immunosuppressed. The forthcoming change, following recommendations and assessments of public health benefit and cost-effectiveness, will see the vaccine widely offered to eligible children as part of their scheduled immunisations.

Introducing the vaccine into the routine schedule is expected to bring substantial public health benefits. A widespread vaccination programme can lead to a significant reduction in chickenpox cases, decreasing the number of children experiencing the illness and subsequently reducing hospitalisations, GP visits, and school absences. Furthermore, it contributes to 'herd immunity,' offering protection to vulnerable individuals who cannot receive the vaccine themselves, in line with public health objectives often informed by bodies like NICE (National Institute for Health and Care Excellence) in its appraisal of vaccine benefits and value.

Parents and guardians are advised to consult their GP or visit the official NHS website in late 2025 for the most up-to-date information regarding the precise schedule and eligibility criteria for the new chickenpox vaccination programme. Always consult a healthcare professional for specific medical advice relating to your child’s health or vaccination needs.

Why this matters: This change signifies a major step in public health for the UK, aiming to protect children from a common illness and its potential complications. It will reduce the burden on families, schools, and the NHS by preventing illness and hospitalisations.

What this means for you: This story may affect patients, NHS access, appointments or local health services. If it relates to your care, check official NHS guidance or contact the relevant service for personal advice.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.